Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1

from Neurology Minute · host American Academy of Neurology

In part one of this series, Dr. Justin Abbatemarco and Dr. Benjamin P. Trewin discuss the major findings from his work. Read more about this abstract on the AAN website.

Episode metadata supplied by the publisher feed · Published Apr 29, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 1

0:00 4:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neurology Minute?

This episode is 4 minutes long.

When was this Neurology Minute episode published?

This episode was published on April 29, 2026.

Can I download this Neurology Minute episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!